In the News
April 28, 2017
- J. Halperin. Plasma Glycated CD59 (pGCD59) Predicts Early Gestational Diabetes (GDM) and Abnormal Neonatal Outcomes: DALI Study Secondary Analysis. American Diabetes Association 79th Scientific Sessions. San Francisco, California (2019).
- P. Ghosh, et. al. Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance. Diabetes Care (2017) Apr: epub ahead of print.
- J. Halperin. Blood Levels of Glycated CD59 (GCD59) as a Novel Biomarker for Screening and Diagnosis of Gestational Diabetes Mellitus. American Diabetes Association 75th Scientific Sessions. Boston, Massachusetts (2015).
- P. Ghosh, et. al. Blood levels of glycated CD59 (GCD59) as a novel biomarker for glucose handling in humans. 25th International Complement Workshop. Rio de Janeiro, Brazil. Molecular Immunology (2014) 61(2): 210-292.
- P. Ghosh, et. al. Glycation of the Complement Regulatory Protein CD59 is a Novel Biomarker for Glucose Handling in Humans. The Journal of Clinical Endocrinology and Metabolism (2014) 99(6)E999-1006.
- P. Ghosh, et. al. A specific and sensitive assay for blood levels of glycated CD59: A novel biomarker for diabetes. American Journal of Hematology (2013) 88: 670-676.2013.
- J. Halperin, et. al. Chapter 2: Complement and Complement Regulatory Proteins in Diabetes. Inflammatory Pathways in Diabetes: Biomarkers and Clinical Correlates (2015). DOI 10.1007/978-3-319-21927-1_2
- P. Ghosh, et. al. Role of Complement and Complement Regulatory Proteins in the Complications of Diabetes. Endocrine Reviews (2015) 36(3):272-288.
- Xuebin qin, et. al. Glycation Inactivation of the Complement Regulatory Protein CD59. Diabetes (2004) 53:2653-2661.
- J. Acosta, et. al. Molecular basis for a link between complement and the vascular complications of diabetes. Proceedings of the National Academy of Science (2000) 97: 5450-5455, 2000.